Cellectis Inc. (CLLS) Q1 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cellectis S.a..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:05.133 Good morning, everyone, and welcome to the Selectus first quarter 2024 earnings call. 00:00:05.133 -- 00:00:08.076 At this time, all participants are in a listen-only mode. 00:00:08.076 -- 00:00:11.819 Later, we will conduct a question and answer session, and instructions will follow at 00:00:11.819 -- 00:00:16.683 that time. Please be aware that today's conference call is being recorded. 00:00:16.683 -- 00:00:21.908 I'd now like to turn the conference over to your first speaker, Arthur Strill, Interim 00:00:21.908 -- 00:00:24.029 Chief Financial Officer. 00:00:24.029 -- 00:00:26.310 You may begin. 00:00:26.869 -- 00:00:32.011 Good morning, and welcome, everyone, to Selectus' first quarter 2024 corporate update 00:00:32.011 -- 00:00:35.093 and financial results conference call. 00:00:35.093 -- 00:00:39.855 Joining me on the call today are Dr. André Choulika, our chief executive officer, and 00:00:39.855 -- 00:00:43.736 Dr. Mark Fertini, our chief medical officer. 00:00:43.736 -- 00:00:48.779 Yesterday evening, Selectus issued a 6K and a press release reporting our financial statements 00:00:48.779 -- 00:00:53.340 for the three-month period ending March 31, 2024, and a corporate and business update. 00:00:55.131 -- 00:00:59.973 The report and press release are available on our website at selectus.com. 00:01:00.214 -- 00:01:04.898 As a reminder, we will make statements regarding Selectus' financial outlook, including 00:01:04.898 -- 00:01:09.801 the sufficiency of cash-to-fund operations, in addition to its manufacturing, regulatory, 00:01:09.801 -- 00:01:14.044 and product development status, as well as product development status of its licensed 00:01:14.044 -- 00:01:15.645 partners. 00:01:15.645 -- 00:01:19.828 These forward-lookin...